Corporate plasma collection operations prioritizing profit over donor safety, with deaths linked to exploitative collection practices targeting vulnerable populations, exemplifying biopolitical extraction and regulatory capture.
Donating plasma for Grifols at a hospital in Barcelona in 2020. The company has suspended collecting plasma in Canada because of scrutiny over two deaths.
Article documents systemic barriers to safe abortion access in Malawi, forcing women into dangerous unsafe procedures—a clear violation of… [more]
Documents organized effort to restrict access to fertility technologies and reproductive choice, raising concerns about bodily autonomy… [more]
Systemic state failure to provide humane detention conditions, with inmates subjected to dangerous environmental conditions and… [more]